Dr Roland J Reyes, MD | |
1997 Healthway Dr, Suite 203, Avon, OH 44011-2834 | |
(440) 988-6880 | |
(440) 988-6869 |
Full Name | Dr Roland J Reyes |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 38 Years |
Location | 1997 Healthway Dr, Avon, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427035427 | NPI | - | NPPES |
0999737 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 35-061473 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Angels Care Home Health Of Ohio | Fairlawn, OH | Home health agency |
University Hospitals - Elyria Medical Center | Elyria, OH | Hospital |
Uh St John Medical Center | Westlake, OH | Hospital |
University Hospitals Of Cleveland | Cleveland, OH | Hospital |
Mercy Regional Medical Center | Lorain, OH | Hospital |
Cleveland Clinic | Cleveland, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
Glaucoma in developing countries represents a significant health crisis. The great majority of people in developing countries aren't ever tested for glaucoma, so diagnosis and treatment are rare. And if they are diagnosed, they often can't pay for medication, assuming medications are available.
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Pharmaceutical research and biotechnology companies based in California are researching and developing 58 new medicines for diabetes, a chronic disease that afflicts 220 million patients worldwide, including 23.6 million Americans, a new report shows.
› Verified 9 days ago
Entity Name | University Primary Care Practices Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
Glaucoma in developing countries represents a significant health crisis. The great majority of people in developing countries aren't ever tested for glaucoma, so diagnosis and treatment are rare. And if they are diagnosed, they often can't pay for medication, assuming medications are available.
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Pharmaceutical research and biotechnology companies based in California are researching and developing 58 new medicines for diabetes, a chronic disease that afflicts 220 million patients worldwide, including 23.6 million Americans, a new report shows.
› Verified 9 days ago
Entity Name | University Hospitals Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
Glaucoma in developing countries represents a significant health crisis. The great majority of people in developing countries aren't ever tested for glaucoma, so diagnosis and treatment are rare. And if they are diagnosed, they often can't pay for medication, assuming medications are available.
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Pharmaceutical research and biotechnology companies based in California are researching and developing 58 new medicines for diabetes, a chronic disease that afflicts 220 million patients worldwide, including 23.6 million Americans, a new report shows.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Roland J Reyes, MD 1997 Healthway Dr, Suite 203, Avon, OH 44011-2834 Ph: (440) 988-6880 | Dr Roland J Reyes, MD 1997 Healthway Dr, Suite 203, Avon, OH 44011-2834 Ph: (440) 988-6880 |
News Archive
Glaucoma in developing countries represents a significant health crisis. The great majority of people in developing countries aren't ever tested for glaucoma, so diagnosis and treatment are rare. And if they are diagnosed, they often can't pay for medication, assuming medications are available.
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Pharmaceutical research and biotechnology companies based in California are researching and developing 58 new medicines for diabetes, a chronic disease that afflicts 220 million patients worldwide, including 23.6 million Americans, a new report shows.
› Verified 9 days ago
Dr. Edward A Levy, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33100 Cleveland Clinic Blvd, Mail Code Avw3-1, Avon, OH 44011 Phone: 440-695-4000 Fax: 440-695-4389 |